Covered recipient · General Payments record
CAROLINA G SIERRA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$3,495.90
- Reported across 125 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $746.44 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $406.02 | 10 |
| Lilly USA, LLC | $260.57 | 9 |
| Antares Pharma, Inc. | $35.74 | 2 |
| Alexion Pharmaceuticals, Inc. | $23.11 | 1 |
| ABBVIE INC. | $21.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.00 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106101275 | CMS |
| Alexion Pharmaceuticals, Inc. | $23.11 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093994718 | CMS |
| Antares Pharma, Inc. | $18.65 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146485719 | CMS |
| Antares Pharma, Inc. | $17.09 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146485723 | CMS |
| Lilly USA, LLC | $18.99 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136086932 | CMS |
| Lilly USA, LLC | $3.70 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136088122 | CMS |
| Lilly USA, LLC | $16.35 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136084568 | CMS |
| Lilly USA, LLC | $24.26 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136087244 | CMS |
| Lilly USA, LLC | $15.93 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136086934 | CMS |
| Lilly USA, LLC | $19.06 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136087772 | CMS |
| Lilly USA, LLC | $19.58 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136084566 | CMS |
| Lilly USA, LLC | $18.24 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136037129 | CMS |
| Lilly USA, LLC | $124.46 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136088124 | CMS |
| Novo Nordisk Inc | $12.53 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097014335 | CMS |
| Novo Nordisk Inc | $125.00 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096995998 | CMS |
| Novo Nordisk Inc | $15.60 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096728290 | CMS |
| Novo Nordisk Inc | $23.67 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096777214 | CMS |
| Novo Nordisk Inc | $10.61 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096904067 | CMS |
| Novo Nordisk Inc | $124.99 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096686740 | CMS |
| Novo Nordisk Inc | $23.78 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097391070 | CMS |
| Novo Nordisk Inc | $22.73 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097423077 | CMS |
| Novo Nordisk Inc | $26.26 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096990134 | CMS |
| Novo Nordisk Inc | $20.85 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097691589 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.